MARSHA J. PECHMAN, Chief District Judge.
THIS MATTER comes before the Court on Defendant Albion Laboratories, Inc.'s Motion to Dismiss the First Amended Complaint Pursuant to FRCP 9(b) and 12(b)(6). (Dkt. No. 29.) Having reviewed the Motion, Plaintiff Donna Copeland's Response (Dkt. No. 32), Albion's Reply (Dkt. No. 37), and having heard oral argument on November 9, 2015, the Court hereby GRANTS the Motion.
According to the First Amended Complaint, Plaintiff and putative class representative Donna Copland began taking magnesium as a dietary supplement to treat pain due to fibrocystic breasts. (FAC, Dkt. No. 26 at 3.) At first she took magnesium citrate, but then learned that the absorption rate for magnesium citrate is low. (
Plaintiff alleges that magnesium glycinate, a "chelated" form of magnesium, is more easily absorbed and "bioavailable" than magnesium oxide and thus more attractive to consumers, but it is also more expensive to manufacture. (Dkt. No. 26 at 8.) Both Designs for Health and Seeking Health sell magnesium supplements containing Albion's product, a blend of both magnesium glycinate and magnesium oxide. (Dkt. No. 26 at 3-4.) Designs for Health's product is labeled "Magnesium Glycinate Chelate" and its ingredient list specifies that the magnesium is "TRAACS® Magnesium Glycinate Chelate Buffered." (Dkt. No. 26 at 9, 15.) TRAACS® is Albion's registered trademark. (
Relying on the labels, Plaintiff alleges that she purchased Albion's magnesium supplements from Designs for Health and from Seeking Health, abandoning each re-seller in turn when she learned that the supplements contained magnesium oxide in addition to magnesium glycinate. (Dkt. No. 26 at 3-4.) Plaintiff alleges Albion had the right to control the labeling used by its re-sellers. As evidence to support this contention, Plaintiff cites the example of a third reseller (neither Designs for Health nor Seeking Health), which stated in an email to Plaintiff's former counsel in response to a review he posted on Amazon.com and a previous email from him, "[W]e label all ingredients in strict accordance with the requirements legally set forth by Albion Nutrition. If we didn't label our product exactly as Albion dictates, we simply couldn't advertise the fact that we use their ingredients." (Dkt. No. 26 at 13; Dkt. No. 1, Ex. C at 49.) Plaintiff also alleges a representative of the re-seller wrote in comments to an online review, "Albion, did review, direct, and approve the current content of our label, with instructions to label the ingredient in question as TRAACS® Magnesium Glycinate Chelate Buffered. There is also a contract in place between us which governs all Albion trademarks and descriptions." (Dkt. No. 26 at 13-14.)
Plaintiff has claims against Designs for Health and Seeking Health as well, but the claims relevant to Albion's motion are Claim 5 (against Albion only), violation of the Utah Consumer Sales Practices Act (deceptive practices), Utah Code § 13-11-4(2); Claim 6 (against Albion only), violation of the Utah Consumer Sales Practices Act (unconscionable practices), Utah Code § 13-11-5(1); Claim 7 (against Albion and both re-sellers), unjust enrichment; and Claim 8 (against Albion and both re-sellers), fraud by omission.
Albion now asks the Court to dismiss the claims against it for failure to plead facts with the requisite specificity as to the fraud claim under Federal Rule of Civil Procedure 9(b) and for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6).
To survive a motion to dismiss, a complaint must state a claim for relief that is plausible on its face. Fed. R. Civ. P. 12(b)(6);
Courts follow a two-step approach when deciding whether a complaint survives a 12(b)(6) motion.
When evaluating a motion to dismiss, the Court examines fraud-based claims in accordance with the heightened pleading standard of Federal Rule of Civil Procedure 9(b).
Albion argues Texas, not Utah, law applies to Plaintiff's claims against it because Plaintiff resides in Texas and "presumably made the decision to purchase the products online while in Texas." (Dkt. No. 29 at 14-15.) Albion further invites the Court to dismiss the Utah statutory claims on the basis that Texas law applies. (Dkt. No. 29 at 16 n.5.) Because choice of law depends in part on facts not alleged in the pleadings, the Court declines to decide choice of law at this time.
The Utah Consumer Sales Practices Act ("UCSPA") "generally prohibits deceptive or unconscionable acts or practices by a supplier in connection with a consumer transaction."
Both of Plaintiff's claims apply only to acts by a "supplier," defined as "a seller, lessor, assignor, offeror, broker, or other person who regularly solicits, engages in, or enforces consumer transactions, whether or not he deals directly with the consumer." UCSPA § 13-11-3; § 13-11-4; 13-11-5. A "consumer transaction," meanwhile, is defined in relevant part here as "a sale, lease, assignment, award by chance, or other written or oral transfer or disposition of goods, services, or other property, both tangible and intangible (except securities and insurance) to, or apparently to, a person for: (i) primarily personal, family, or household purposes . . . ." UCSPA § 13-11-3(2)(a).
The Utah Consumer Sales Practices Act is based on the Uniform Consumer Sales Practices Act.
Albion is correct that some Utah courts have been skeptical of the application of the definition to parties once removed from the alleged consumer transaction.
The Utah Supreme Court has held that a manufacturer qualified as a supplier under the UCSPA where the manufacturer made allegedly deceptive representations in promotional materials that were supplied to a consumer via an intermediary.
While Plaintiff interprets these cases as holding that "supplier" liability can attach to Albion merely through the quality guarantees represented by the Albion medallion and TRAACS trademark (Dkt. No. 32 at 10), Albion correctly points out that the cases hold that the initial seller must directly engage in the deceptive representation to be held liable. (Dkt. No. 37 at 4.) This debate ultimately goes to the question whether Plaintiff has stated Albion's liability for the re-sellers' statements with the requisite particularity, not whether Albion is inherently protected against liability under the UCSPA by virtue of its place in the chain of commerce.
Albion next argues that even if Plaintiff can assert Albion's liability as a supplier, she fails to do so with the requisite particularity. Rule 9(b) applies to UCSPA claims based on deceptive conduct.
Albion argues Plaintiff's claims lack specificity because while she alleges that Albion had the right to control
Plaintiff's citation to various communications with a third-party re-seller about Albion's control over the third party's representations is not helpful here. Particularity under Rule 9(b) is distinct from plausibility under Rule 8(b), and it requires the pleader to cite facts supporting the attribution of third party statements to the defendant.
Albion argues Plaintiff has failed to state an unjust enrichment claim under Texas law (Dkt. No. 29 at 16-23) or Utah law (Dkt. No. 29 at 24). Under either state's law, Albion argues that since Albion disclosed the fact that the supplements contained magnesium oxide on the product data sheet it disseminated to its customers, Plaintiff has not plausibly alleged that Albion was able to retain any unjust benefit Plaintiff conferred at the retail level. (See Dkt. No. 29 at 23.) The Court agrees that Plaintiff did not directly confer any benefit on Albion, and Plaintiff has failed to allege specific facts making this attenuated trickle-up theory of unjust enrichment plausible.
Albion next argues that Plaintiff's fraud by omission claim fails because Plaintiff has not adequately alleged a duty to disclose facts about the composition of its supplements to Plaintiff. (Dkt. No. 29 at 25.)
Plaintiff alleges Albion had a duty to disclose where the alleged "defect is not discoverable by reasonable care." (Dkt. No. 32 at 19.) The case law Plaintiff cites for this proposition, however, is specific to the sale of real property and is not relevant here.
In Texas, a duty to disclose can arise in four circumstances: (1) a fiduciary or other special relationship between the parties; (2) new information makes a defendant's earlier representation misleading or untrue; (3) a defendant conveys a false impression by making a partial disclosure; and (4) a defendant who voluntarily discloses information has a duty to disclose the whole truth.
Because Plaintiff has failed to plead with particularity her UCSPA and fraud claims and has failed to state a claim with respect to her unjust enrichment claim, Albion's Motion to Dismiss is GRANTED with prejudice.
The clerk is ordered to provide copies of this order to all counsel.